BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

HanAll BioPharma Co., Ltd. 

6th Fl, I-Space Building, 11-10
Sincheon-Dong
Seoul    138-922  Korea
Phone: 82-2-2204-1753-9 Fax: 82-2-414-1951


SEARCH JOBS










 Company News
HanAll BioPharma Co., Ltd. (009420.KS) Release: U.S. IND Accepted by the FDA in Support of the Clinical Development HL 007, a Unique Fixed Dose Combination to Treat Cardiovascular Disease 7/9/2010 5:09:00 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) Receives U.S. PTO Notice Of Allowance For Vitatropin(TM), Modified Human Growth Hormone 4/2/2010 12:32:03 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) Receives Issue Notification from the U.S. Patent and Trademark Office for its lead Hanferon(TM) (Protease resistant Interferon-alpha) Molecule 11/24/2009 1:17:32 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) Awarded $3.2 MM USD from the South Korean Government to Support Global Development of its Novel Hanferon(TM) SC Protein Therapeutic 7/21/2009 2:05:01 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) Acquires Global Rights To Nautilus Biotech's Protein Engineering Technology For Developing Novel Oral And Injectable Therapeutic Proteins 6/29/2009 1:49:11 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) And Yuhan Corporation Complete License Agreement For A Unique Cardiovascular Combination Product For The Korean Market 6/4/2009 12:56:43 PM    More...
Han All Pharmaceutical Co., Ltd. (009420.KS) to Present its Oral and Injectable Protein Therapeutic Program at 2009 Biotechnology Industry Organization (BIO) International Conference 5/14/2009 3:05:12 PM    More...
Nautilus Biotech and Han All Pharmaceutical Co., Ltd. (009420.KS) Announce License Agreement to Develop Three Nautilus Biotech Products in South Korea 3/6/2007 1:15:53 PM    More...
Atrix Laboratories, Inc. (ATRX) Licenses Prostate Cancer Products In Korea 10/19/2005 5:09:49 PM    More...